{"id":"prophylactic-vancomycin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Ototoxicity"},{"rate":null,"effect":"Red man syndrome (flushing, erythema)"},{"rate":null,"effect":"Phlebitis at infusion site"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL262777","moleculeType":"Small molecule","molecularWeight":"1449.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vancomycin binds to the terminal D-alanyl-D-alanine residues of peptidoglycan precursors in bacterial cell walls, blocking the cross-linking reactions catalyzed by transpeptidases. This prevents proper cell wall formation and integrity, leading to bacterial cell lysis and death. In prophylactic use, vancomycin is administered to prevent bacterial infections in immunocompromised cancer patients at high risk of infection.","oneSentence":"Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors, preventing cross-linking and causing cell wall disruption.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:30:26.635Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of bacterial infections in immunocompromised cancer patients undergoing chemotherapy"}]},"trialDetails":[{"nctId":"NCT05421741","phase":"PHASE4","title":"Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-05-15","conditions":"Osteomyelitis Tibia, Tibial Fractures, Open Tibia Fracture","enrollment":484},{"nctId":"NCT04731025","phase":"PHASE3","title":"Local Antibiotics for Breast Implants","status":"RECRUITING","sponsor":"Mikkel Herly","startDate":"2021-01-27","conditions":"Implant Complication, Implant Infection, Implant Site Infection","enrollment":1003},{"nctId":"NCT03283878","phase":"PHASE4","title":"Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial","status":"COMPLETED","sponsor":"Duke University","startDate":"2017-10-24","conditions":"Arthropathy of Knee, Antibiotic Prophylaxis","enrollment":1770},{"nctId":"NCT07338773","phase":"PHASE4","title":"Intraosseous vs. Intravenous Vancomycin Prophylaxis for Diabetic Foot Amputations: A Randomized Trial","status":"RECRUITING","sponsor":"Başakşehir Çam & Sakura City Hospital","startDate":"2025-09-03","conditions":"Diabetic Foot Disease, Diabetic Foot Infection, Diabetic Amputation Foot Wound","enrollment":40},{"nctId":"NCT06970262","phase":"NA","title":"FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-05-20","conditions":"Lung Infection, Microbial Colonization, Food Intolerance Syndromes","enrollment":150},{"nctId":"NCT04678154","phase":"PHASE3","title":"Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-07","conditions":"Post Operative Surgical Site Infection","enrollment":1200},{"nctId":"NCT06814223","phase":"PHASE4","title":"Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement","status":"RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2024-10-28","conditions":"Infection Catheter-Related","enrollment":200},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT03839914","phase":"NA","title":"Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2020-08-01","conditions":"Spinal Deformity, Trauma, Spinal Tumor","enrollment":76},{"nctId":"NCT06439953","phase":"NA","title":"Irrisept Solution for Instrumented Spine Surgery","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2024-10-01","conditions":"Post-Op Complication, Spine Surgery, Site Infection","enrollment":200},{"nctId":"NCT04401553","phase":"PHASE4","title":"Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-08-16","conditions":"Surgical Site Infection, Beta-lactam Allergy","enrollment":""},{"nctId":"NCT03466502","phase":"PHASE4","title":"Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics","status":"COMPLETED","sponsor":"University of Nevada, Reno","startDate":"2018-03-08","conditions":"Clostridium Difficile Infection","enrollment":104},{"nctId":"NCT05651464","phase":"NA","title":"Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation","status":"UNKNOWN","sponsor":"Universität des Saarlandes","startDate":"2023-01-01","conditions":"Catheter-Related Infections","enrollment":42},{"nctId":"NCT02374853","phase":"PHASE2","title":"Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2015-03","conditions":"INFECTION","enrollment":1037},{"nctId":"NCT00634166","phase":"PHASE4","title":"Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group","status":"TERMINATED","sponsor":"Mylan Inc.","startDate":"2007-09","conditions":"Burns","enrollment":220},{"nctId":"NCT05297513","phase":"PHASE4","title":"Efficacy of ActiveMatrix on Spinal SSI Rate","status":"NOT_YET_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2022-07","conditions":"Spinal Stenosis Lumbar, Surgical Site Infection, Back Pain Lower Back Chronic","enrollment":275},{"nctId":"NCT03432858","phase":"PHASE4","title":"Preoperative Antibiotics for Carpal Tunnel Release Surgery","status":"COMPLETED","sponsor":"WellSpan Health","startDate":"2018-05-17","conditions":"Carpal Tunnel Syndrome","enrollment":184},{"nctId":"NCT02227446","phase":"PHASE3","title":"Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2014-10","conditions":"Post Operative Surgical Site Infection","enrollment":1036},{"nctId":"NCT03506347","phase":"PHASE2, PHASE3","title":"Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-24","conditions":"Arthropathy of Knee Joint","enrollment":24},{"nctId":"NCT02384200","phase":"PHASE4","title":"A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-03","conditions":"Nephrolithiasis, Urinary Tract Infections","enrollment":86},{"nctId":"NCT03308253","phase":"PHASE4","title":"Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2018-07-16","conditions":"Surgical Site Infection","enrollment":60},{"nctId":"NCT02020031","phase":"PHASE2, PHASE3","title":"Regional Prophylactic Vancomycin in Revision Total Knee Replacement","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-12","conditions":"Arthropathy of Knee Joint","enrollment":22},{"nctId":"NCT01019681","phase":"PHASE1","title":"Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia","status":"TERMINATED","sponsor":"Richard Burt, MD","startDate":"2009-11","conditions":"Critical Limb Ischemia","enrollment":1},{"nctId":"NCT01174212","phase":"PHASE4","title":"Effect of Prophylactic Antibiotics on Intra-Operative Culture Results","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-07","conditions":"Infection, Arthroplasty","enrollment":65},{"nctId":"NCT00035425","phase":"PHASE3","title":"Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-11","conditions":"Febrile Neutropenia","enrollment":120},{"nctId":"NCT00138112","phase":"PHASE3","title":"Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-11","conditions":"Streptococcal Sepsis, Hematologic Malignancies","enrollment":126}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":77,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Prophylactic Vancomycin","genericName":"Prophylactic Vancomycin","companyName":"Memorial Sloan Kettering Cancer Center","companyId":"memorial-sloan-kettering-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors, preventing cross-linking and causing cell wall disruption. Used for Prophylaxis of bacterial infections in immunocompromised cancer patients undergoing chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}